—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Ascendis Pharma AS (ASND) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 53 out of 100 (momentum 65 · quality 63 · valuation 24), as of 2026-11-11.
  • Signal: Uptrend stack intact — Trades +5.8% vs the 50-day and +7.2% vs the 200-day average, 9.1% below the 52-week high and +36.4% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
  • Trend: Ascendis Pharma AS trades 5.8% above its 50-day and 7.2% above its 200-day moving average. (as of 2026-11-10)

Ascendis Pharma builds drugs on its TransCon platform, which controls how a molecule releases in the body over time. It sells Skytrofa for children with growth hormone deficiency and Yorvipath for adults with chronic hypoparathyroidism.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ASND overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +5.8% vs the 50-day and +7.2% vs the 200-day average, 9.1% below the 52-week high and +36.4% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the ASND chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on ASND?

Uptrend stack intact — Trades +5.8% vs the 50-day and +7.2% vs the 200-day average, 9.1% below the 52-week high and +36.4% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ASND above its 50-day and 200-day moving averages?

As of 2026-11-10, Ascendis Pharma AS trades +5.8% above its 50-day and +7.2% above its 200-day average, with the 20-day +4.8% away.

How far is ASND from its 52-week high?

9.1% below the 52-week high and 36.4% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.